Literature DB >> 16675777

Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis.

Elizabeth F Shead1, Charles S Haworth, Elaine Gunn, Diana Bilton, Mike A Scott, Juliet E Compston.   

Abstract

RATIONALE: Adults with cystic fibrosis (CF) are at increased risk of developing osteoporosis. During infective exacerbations, increased production of proinflammatory cytokines and markers of bone resorption have been reported.
OBJECTIVE: The aim of this study is to investigate the growth and proliferation of potential osteoclast precursor cells before, during, and after intravenous antibiotic treatment of infective exacerbations in patients with CF.
METHODS: Hematopoietic precursor cell growth was examined using colony formation assays using Methocult culture medium. Circulating potential osteoclast precursors were identified using four-color flow cytometry by CD14, CD33, CD34, and CD45 expression.
RESULTS: At the start of an infective exacerbation increases in hematopoietic precursor colony formation (15.42 colonies/10(5) cells plated, p = 0.025), proliferation (28.5%, p < 0.001), and the numbers of circulating potential osteoclast precursors (6.5%, p < 0.001) were seen in comparison with baseline levels. These increases declined after treatment with intravenous antibiotics to a level close to baseline.
CONCLUSIONS: The results demonstrate an increase in the production of potential osteoclast precursors in the peripheral blood during CF infective exacerbations. This may result in increased bone resorption and contribute to bone loss in patients with CF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675777     DOI: 10.1164/rccm.200512-1943OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

Review 1.  Update in cystic fibrosis 2006.

Authors:  Frank J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2007-04-15       Impact factor: 21.405

2.  Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients.

Authors:  D Gensburger; S Boutroy; R Chapurlat; R Nove-Josserand; S Roche; M Rabilloud; I Durieu
Journal:  Osteoporos Int       Date:  2016-05-11       Impact factor: 4.507

Review 3.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

4.  Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study.

Authors:  Hiromu Tanaka; Takanori Asakura; Shoji Suzuki; Satoshi Okamori; Tatsuya Kusumoto; Takunori Ogawa; Shunsuke Uno; Atsuho Morita; Ho Lee; Ho Namkoong; Hirofumi Kamata; Yasunori Sato; Yoshifumi Uwamino; Tomoyasu Nishimura; Makoto Ishii; Koichi Fukunaga; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2022-05-21       Impact factor: 3.320

Review 5.  Cystic fibrosis-related bone disease: insights into a growing problem.

Authors:  Michael S Stalvey; Gregory A Clines
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-12       Impact factor: 3.243

6.  Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.

Authors:  Troy D Pashuck; Sarah E Franz; Molly K Altman; Clive H Wasserfall; Mark A Atkinson; Thomas J Wronski; Terence R Flotte; Michael S Stalvey
Journal:  Pediatr Res       Date:  2009-03       Impact factor: 3.756

7.  Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).

Authors:  Alexandra Papaioannou; Courtney C Kennedy; Andreas Freitag; George Ioannidis; John O'Neill; Colin Webber; Margaret Pui; Yves Berthiaume; Harvey R Rabin; Nigel Paterson; Alphonse Jeanneret; Elias Matouk; Josee Villeneuve; Madeline Nixon; Jonathan D Adachi
Journal:  Chest       Date:  2008-07-18       Impact factor: 9.410

8.  Osteoporosis Is Associated with Deteriorating Clinical Status in Adults with Cystic Fibrosis.

Authors:  Inger Hee Mathiesen; Tacjana Pressler; Peter Oturai; Terese Lea Katzenstein; Marianne Skov; Ruth Frikke-Schmidt; Mette Friberg Hitz
Journal:  Int J Endocrinol       Date:  2018-03-26       Impact factor: 3.257

9.  Lung-Specific Risk Factors Associated With Incident Hip Fracture in Current and Former Smokers.

Authors:  Jessica Bon; Seyed Mehdi Nouraie; Kenneth J Smith; Mark T Dransfield; Merry-Lynn McDonald; Eric A Hoffman; John D Newell; Alejandro P Comellas; Punam K Saha; Russell P Bowler; Elizabeth A Regan
Journal:  J Bone Miner Res       Date:  2020-08-04       Impact factor: 6.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.